ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MARCO RODRIGUEZ APONTE MD

1326 CALLE SALUD EDIFICIO EL SENORIAL PLAZA SUITE 305

Ponce | Puerto Rico | 00717

(787) 842-4668

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,574Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 190

$1.35M Total Retail Price of All Prescriptions

Rank: 3 out of 190

1,617 Patients Receiving at Least One Drug in Part D
35%Patients 65 Years and Older
5% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

10% of this provider’s 6,544 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 5%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
FLUOXETINE HCL 2,520 629 10 1 1
RISPERIDONE 2,015 546 10 2 5
PAROXETINE HCL 1,715 515 10 3 4
SERTRALINE HCL 1,535 540 4 3
ZOLPIDEM TARTRATE 1,510 522 5 2
DOXEPIN HCL 1,325 233 10 6 12
CITALOPRAM HBR 1,129 598 7 6
BENZTROPINE MESYLATE 941 245 R 8 15
TRAZODONE HCL 881 143 9 7
DIVALPROEX SODIUM 588 76 10 14
BUPROPION HCL SR 588 81 10 10 17
QUETIAPINE FUMARATE 587 185 12 9
VENLAFAXINE HCL ER 539 76 13 13
HALOPERIDOL 512 104 14 21
DIPHENHYDRAMINE HCL 504 114 R 10 15 20
BUPROPION XL 493 43 16 8
CYMBALTA 445 39 17 10
AMITRIPTYLINE HCL 425 160 R 18 11
BUSPIRONE HCL 413 161 19 16
OLANZAPINE 346 152 20 19
LITHIUM CARBONATE 336 15 21 27
SEROQUEL 324 124 22 22
ABILIFY 319 55 23 18
MIRTAZAPINE 302 90 24 25
PERPHENAZINE 298 61 25 39
CHLORPROMAZINE HCL 247 36 26 26
SEROQUEL XR 220 11 27 34
HYDROXYZINE PAMOATE 216 42 R 28 23
RANITIDINE HCL 195 37 29 37
THIORIDAZINE HCL 189 29 R 30 35
HYDROXYZINE HCL 176 61 R 31 50
DONEPEZIL HCL 166 133 32 29
HALOPERIDOL DECANOATE 161 49 33 55
THIOTHIXENE 142 12 34 41
NORTRIPTYLINE HCL 118 77 35 42
FLUPHENAZINE HCL 114 33 36 46
GABAPENTIN 112 19 37 38
VENLAFAXINE HCL 103 15 38 40
ZIPRASIDONE HCL 90 0 39 45
CLOZAPINE 87 0 40 51
ESCITALOPRAM OXALATE 87 38 40 33
SAPHRIS 86 0 42 85
FLUPHENAZINE DECANOATE 85 23 43 65
DIVALPROEX SODIUM ER 83 44 44 31
PRISTIQ ER 81 18 45 32
BUDEPRION SR 72 0 10 46 52
GEODON 71 0 47 62
LORAZEPAM 59 26 48 56
TRIFLUOPERAZINE HCL 56 0 49 30
CLONAZEPAM 54 22 50 28
LATUDA 50 0 51 100
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.